| Drug Name | Kymriah (tisagenlecleucel) |
|---|---|
| Drug Class |
Anticancer
|
| Risk minimization type |
Other
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
risk of Cytokine release syndrome and neurological events |
| other |
Kymriah
Kymriah |